PHNTX Director of Clinical Research Dr. Gary Sinclair Developing new forms of PrEP is key to ending AIDS, medical professionals say CAROLINE SAVOIE | Contributing Writer CaroSavoWrites@gmail.com Much has changed in the world of HIV pre-exposure prophylaxis (PrEP) in the four years since COVID-19 shut down the world — from delivery methods to length of time between treatments.
In 2024, there are more PrEP products available than ever before, giving hope to researchers and providers chasing the goal of ending the U.S.’s HIV epidemic by 2030.
According to the CDC, an estimated 40 million people are living with HIV worldwide, with 1.2 million of those people living in the U.S.
About 10 million of the people living with HIV do not have access to treatment. NTIDC Physician’s Assistant Erin Duhaime The Texas Department of Health and Human Services reported that in 2022, 40,000 Texans were on PrEP.